Who
Anthony Digiandomenico
Director
Company insider
Files Form 4 as: Director, ClearSign Technologies; Director, ENDRA Life Sciences; Co-Founder, MDB Capital Holdings; Director, Provention Bio; Director, Cue Biopharma; Director, Bazi International.
In numbers
- Trades disclosed
- 109
- Buys
- 54
- Sells
- 0
- Bought
- $1.6M
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 4 Aug 2006
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —3,766 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,595 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,595 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —3,024 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —3,024 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —60,324 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —60,324 at $0.00 | filing |
| 10 Oct 2025filed 15 Oct 2025 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | $1.0M141,644 at $7.06 | filing |
| 10 Oct 2025filed 15 Oct 2025 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | $500K70,822 at $7.06 | filing |
| 11 Jun 2025filed 1 Jul 2025 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —5,384 at $0.00 | filing |
| 28 Apr 2025filed 8 Aug 2025 | MDBH MDB Capital Holdingsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code D | —900,000 at $0.00 | filing |
| 28 Apr 2025filed 8 Aug 2025 | MDBH MDB Capital Holdingsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —900,000 at $0.00 | filing |
| 28 Apr 2025filed 29 Apr 2025 | MDBH MDB Capital Holdingsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code D | —900,000 at $0.00 | filing |
| 28 Apr 2025filed 29 Apr 2025 | MDBH MDB Capital Holdingsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —900,000 at $0.00 | filing |
| 7 Apr 2025filed 8 Aug 2025 | MDBH MDB Capital HoldingsConsumer & Specialty Finance | SEC FORM 4 Bought | $6,9831,425 at $4.90 | filing |
| 7 Apr 2025filed 9 Apr 2025 | MDBH MDB Capital HoldingsConsumer & Specialty Finance | SEC FORM 4 Bought | $6,9831,425 at $4.90 | filing |
| 13 Feb 2025filed 14 Feb 2025 | MDBH MDB Capital HoldingsConsumer & Specialty Finance | SEC FORM 4 Bought | $5,793942 at $6.15 | filing |
| 12 Feb 2025filed 14 Feb 2025 | MDBH MDB Capital HoldingsConsumer & Specialty Finance | SEC FORM 4 Bought | $1,784290 at $6.15 | filing |
| 11 Feb 2025filed 11 Feb 2025 | MDBH MDB Capital HoldingsConsumer & Specialty Finance | SEC FORM 4 Bought | $6,2201,000 at $6.22 | filing |
| 7 Feb 2025filed 11 Feb 2025 | MDBH MDB Capital HoldingsConsumer & Specialty Finance | SEC FORM 4 Bought | $6,2201,000 at $6.22 | filing |
News
MDB Capital (NASDAQ:MDBH) Stock: Insider Jeremy William James Sells 10,000 SharesMDBH · dailypolitical.com · 15 Oct 2026Cue Biopharma (NASDAQ:CUE) Stock: Insider Michael Vincent Meluzio Sells 1,144 SharesCUE · dailypolitical.com · 15 Oct 2026Cue Biopharma (NASDAQ:CUE) Insider Sells $51,724.20 in StockCUE · themarketsdaily.com · 15 Oct 2026Contrasting Cue Biopharma (NASDAQ:CUE) & REGENXBIO (NASDAQ:RGNX)CUE · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Anthony Digiandomenico; 4 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.